Registry › XF-9INH2MH-A
XF-9INH2MH-A
Second Party Opinion ACTIVE

ISS ESG Second Party Opinion — Teva Pharmaceutical Industries Ltd.

Document Metadata

Issuer
Teva Pharmaceutical Industries Ltd.
Document Type
Second Party Opinion
Publication Year
2022
Retrieved
20 March 2026
Source
Contact XFID for Access
Record ID
XF9INH2MHA
Validation
Inferred by XFID

Verification

XFIDs are content-addressed: these SHA-256 fingerprints let anyone confirm a copy of this document is identical to what XFID retrieved on 20 March 2026 — independent of this registry.

SHA-256 (file bytes)
a49edbd165bd450f86aca02f35af00d7a4fc2013fc9b71c5ea47f7d923105cfd
SHA-256 (canonical content)
9a0467cfe05bb6519e902994cd087e7b4ab885dd50960e540510250a398f9316
File
937 KB

The canonical-content hash survives re-downloads, URL moves, and byte-level re-encodes: the same disclosure text always resolves to this XFID.

Assessment Provider

ISS ESG Provider

People Cited in This Document

Version History

Retrieved Action Size
20/03/2026 INITIAL 937 KB latest

How to Cite This Record

Use the XFID in citations to create a stable, permanent reference that resolves to this registry entry regardless of the source URL.

Academic / report citation
Teva Pharmaceutical Industries Ltd. (2022). ISS ESG Second Party Opinion — Teva Pharmaceutical Industries Ltd.. XFID: XF-9INH2MH-A. Retrieved from https://xframework.id/XF9INH2MHA
Identifier only
XF-9INH2MH-A